DK0668279T3 - 6-azaindol thromboxansytaseinhibitor - Google Patents

6-azaindol thromboxansytaseinhibitor

Info

Publication number
DK0668279T3
DK0668279T3 DK95300551T DK95300551T DK0668279T3 DK 0668279 T3 DK0668279 T3 DK 0668279T3 DK 95300551 T DK95300551 T DK 95300551T DK 95300551 T DK95300551 T DK 95300551T DK 0668279 T3 DK0668279 T3 DK 0668279T3
Authority
DK
Denmark
Prior art keywords
azaindole
thromboxane synthase
synthase inhibitor
integer
zero
Prior art date
Application number
DK95300551T
Other languages
Danish (da)
English (en)
Inventor
Joseph Anthony Jakubowski
Alan David Palkowitz
Sandra Kay Sigmund
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0668279T3 publication Critical patent/DK0668279T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95300551T 1994-01-31 1995-01-30 6-azaindol thromboxansytaseinhibitor DK0668279T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/189,212 US5468757A (en) 1994-01-31 1994-01-31 6-azaindole thromboxane synthase inhibitors

Publications (1)

Publication Number Publication Date
DK0668279T3 true DK0668279T3 (da) 2001-08-27

Family

ID=22696403

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95300551T DK0668279T3 (da) 1994-01-31 1995-01-30 6-azaindol thromboxansytaseinhibitor

Country Status (11)

Country Link
US (1) US5468757A (ja)
EP (1) EP0668279B1 (ja)
JP (1) JPH0853448A (ja)
AT (1) ATE202103T1 (ja)
CA (1) CA2141231A1 (ja)
DE (1) DE69521223T2 (ja)
DK (1) DK0668279T3 (ja)
ES (1) ES2157292T3 (ja)
GR (1) GR3036570T3 (ja)
PT (1) PT668279E (ja)
SI (1) SI0668279T1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999020260A2 (en) * 1997-10-17 1999-04-29 Eurogene Limited The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
CN1279682A (zh) 1997-10-20 2001-01-10 霍夫曼-拉罗奇有限公司 双环激酶抑制剂
ES2213984T3 (es) * 1998-10-30 2004-09-01 Eli Lilly And Company Derivados de azaindol y su uso como agentes antitrombicos.
CA2367121A1 (en) * 1999-03-10 2000-09-14 Merck & Co., Inc. 6-azaindole compounds as antagonists of gonadotropin releasing hormone
WO2003009852A1 (en) * 2001-07-24 2003-02-06 Merck & Co., Inc. Tyrosine kinase inhibitors
GB0330043D0 (en) * 2003-12-24 2004-01-28 Pharmacia Italia Spa Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
PE20060430A1 (es) 2004-06-09 2006-05-25 Glaxo Group Ltd Derivados de pirrolopiridina como moduladores de los receptores cannabinoides
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
JP7478142B2 (ja) * 2018-06-07 2024-05-02 ディスアーム セラピューティクス， インコーポレイテッド Ｓａｒｍ１阻害剤
ES2960987T3 (es) 2019-04-12 2024-03-07 Riboscience Llc Derivados de heteroarilo bicíclicos como inhibidores de la ectonucleótido pirofosfatasa fosfodiesterasa 1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101595B (en) * 1981-06-22 1985-05-30 Ciba Geigy Ag Substituted imidazo(1,5-a)pyridines, process for their manufacture, pharmaceutical preparations containing these compounds and their therapeutic application
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
DE3302125A1 (de) * 1983-01-22 1984-07-26 Boehringer Ingelheim KG, 6507 Ingelheim Aminosaeure-derivate, verfahren zu ihrer herstellung und verwendung
FR2658511B1 (fr) * 1990-02-16 1992-06-19 Union Pharma Scient Appl Nouveaux derives de benzimidazole et d'azabenzimidazole, antagonistes des recepteurs au thromboxane; leurs procedes de preparation, compositions pharmaceutiques les contenant.
ATE173251T1 (de) * 1991-08-21 1998-11-15 Eisai Co Ltd Kondensierte pyrimidinderivate als antitumorverbindungen

Also Published As

Publication number Publication date
CA2141231A1 (en) 1995-08-01
EP0668279A2 (en) 1995-08-23
ES2157292T3 (es) 2001-08-16
EP0668279B1 (en) 2001-06-13
GR3036570T3 (en) 2001-12-31
US5468757A (en) 1995-11-21
EP0668279A3 (en) 1995-08-30
DE69521223T2 (de) 2001-11-08
ATE202103T1 (de) 2001-06-15
SI0668279T1 (en) 2001-12-31
PT668279E (pt) 2001-09-28
DE69521223D1 (de) 2001-07-19
JPH0853448A (ja) 1996-02-27

Similar Documents

Publication Publication Date Title
FI965020A (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
PT90623A (pt) Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease
KR970704864A (ko) 세정제 조성물
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
DK0668279T3 (da) 6-azaindol thromboxansytaseinhibitor
ATE232528T1 (de) Pyrimidinylpyrazolderivate
ES2188481T3 (es) Derivados de polinalbufina.
ATE224372T1 (de) Substituierte 6-alkylphenanthridine
PT947504E (pt) Derivados de vitamina d 16-eno
DE69119668D1 (de) Hemmungsstoff für Aldosereduktase
FI940731A (fi) Amiditetratsolit ACAT-inhibiitoreina
ES2169220T3 (es) Derivados de vitamina d3 con sustituyentes en la posicion 2.
FI900796A0 (fi) Aralkylaminfoereningar.
ATE245147T1 (de) Substituierte aminochinazolinon (thion) derivate
ES2093838T3 (es) Inhibidor de fosfolipasa a2.
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
NO20004477L (no) Anvendelse av organiske karbonater for vasking av metalloverflater
DE60221250D1 (de) Bis(5-aryl-2-pyridyl)derivate
ES2121036T3 (es) Derivados de alquilenodiamina.
BR0210201A (pt) Composição
DE60230924D1 (de) 2-substituierte vitamin-d-derivate
TH13791EX (th) อนุพันธ์ต่างๆของกรดบิวไทริค
ES2099621T3 (es) Procedimiento para producir un derivado de imidazol.